Cargando…

Neutralizing Antibodies after Infection with Dengue 1 Virus

Severity of disease is markedly increased when infection with dengue virus type 2 (DENV-2) follows infection with DENV-1. Studies have shown that heterologous neutralizing antibody titers are inversely correlated with severity of a second infection. If this mechanism controlled disease severity in C...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzman, Maria G., Alvarez, Mayling, Rodriguez-Roche, Rosmari, Bernardo, Lídice, Montes, Tibaire, Vazquez, Susana, Morier, Luis, Alvarez, Angel, Gould, Ernest A, Kourí, Gustavo, Halstead, Scott B
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725871/
https://www.ncbi.nlm.nih.gov/pubmed/17479892
http://dx.doi.org/10.3201/eid1302.060539
_version_ 1782170533718130688
author Guzman, Maria G.
Alvarez, Mayling
Rodriguez-Roche, Rosmari
Bernardo, Lídice
Montes, Tibaire
Vazquez, Susana
Morier, Luis
Alvarez, Angel
Gould, Ernest A
Kourí, Gustavo
Halstead, Scott B
author_facet Guzman, Maria G.
Alvarez, Mayling
Rodriguez-Roche, Rosmari
Bernardo, Lídice
Montes, Tibaire
Vazquez, Susana
Morier, Luis
Alvarez, Angel
Gould, Ernest A
Kourí, Gustavo
Halstead, Scott B
author_sort Guzman, Maria G.
collection PubMed
description Severity of disease is markedly increased when infection with dengue virus type 2 (DENV-2) follows infection with DENV-1. Studies have shown that heterologous neutralizing antibody titers are inversely correlated with severity of a second infection. If this mechanism controlled disease severity in Cuba, heterotypic antibody titers should have declined over time. To determine whether phenotypic changes in dengue antibodies occur over time, we analyzed serum samples collected 4–8 and 20–22 years after DENV-1 infection. We found a significant increase in mean titer of homologous DENV-1 neutralizing antibodies and a significant decrease in heterologous antibodies to 1 of 2 genotypes of DENV-2 virus (the American genotype). Asian DENV-2 viruses were not neutralized during either interval; however, the American genotype underwent phenotypic changes in heterotypic viral neutralizing antibodies in the predicted direction. This finding may be related to the time-dependent changes in severity of disease found with secondary dengue infection.
format Text
id pubmed-2725871
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-27258712009-09-10 Neutralizing Antibodies after Infection with Dengue 1 Virus Guzman, Maria G. Alvarez, Mayling Rodriguez-Roche, Rosmari Bernardo, Lídice Montes, Tibaire Vazquez, Susana Morier, Luis Alvarez, Angel Gould, Ernest A Kourí, Gustavo Halstead, Scott B Emerg Infect Dis Research Severity of disease is markedly increased when infection with dengue virus type 2 (DENV-2) follows infection with DENV-1. Studies have shown that heterologous neutralizing antibody titers are inversely correlated with severity of a second infection. If this mechanism controlled disease severity in Cuba, heterotypic antibody titers should have declined over time. To determine whether phenotypic changes in dengue antibodies occur over time, we analyzed serum samples collected 4–8 and 20–22 years after DENV-1 infection. We found a significant increase in mean titer of homologous DENV-1 neutralizing antibodies and a significant decrease in heterologous antibodies to 1 of 2 genotypes of DENV-2 virus (the American genotype). Asian DENV-2 viruses were not neutralized during either interval; however, the American genotype underwent phenotypic changes in heterotypic viral neutralizing antibodies in the predicted direction. This finding may be related to the time-dependent changes in severity of disease found with secondary dengue infection. Centers for Disease Control and Prevention 2007-02 /pmc/articles/PMC2725871/ /pubmed/17479892 http://dx.doi.org/10.3201/eid1302.060539 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Guzman, Maria G.
Alvarez, Mayling
Rodriguez-Roche, Rosmari
Bernardo, Lídice
Montes, Tibaire
Vazquez, Susana
Morier, Luis
Alvarez, Angel
Gould, Ernest A
Kourí, Gustavo
Halstead, Scott B
Neutralizing Antibodies after Infection with Dengue 1 Virus
title Neutralizing Antibodies after Infection with Dengue 1 Virus
title_full Neutralizing Antibodies after Infection with Dengue 1 Virus
title_fullStr Neutralizing Antibodies after Infection with Dengue 1 Virus
title_full_unstemmed Neutralizing Antibodies after Infection with Dengue 1 Virus
title_short Neutralizing Antibodies after Infection with Dengue 1 Virus
title_sort neutralizing antibodies after infection with dengue 1 virus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725871/
https://www.ncbi.nlm.nih.gov/pubmed/17479892
http://dx.doi.org/10.3201/eid1302.060539
work_keys_str_mv AT guzmanmariag neutralizingantibodiesafterinfectionwithdengue1virus
AT alvarezmayling neutralizingantibodiesafterinfectionwithdengue1virus
AT rodriguezrocherosmari neutralizingantibodiesafterinfectionwithdengue1virus
AT bernardolidice neutralizingantibodiesafterinfectionwithdengue1virus
AT montestibaire neutralizingantibodiesafterinfectionwithdengue1virus
AT vazquezsusana neutralizingantibodiesafterinfectionwithdengue1virus
AT morierluis neutralizingantibodiesafterinfectionwithdengue1virus
AT alvarezangel neutralizingantibodiesafterinfectionwithdengue1virus
AT gouldernesta neutralizingantibodiesafterinfectionwithdengue1virus
AT kourigustavo neutralizingantibodiesafterinfectionwithdengue1virus
AT halsteadscottb neutralizingantibodiesafterinfectionwithdengue1virus